1. Home
  2. MREO vs BBCP Comparison

MREO vs BBCP Comparison

Compare MREO & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • BBCP
  • Stock Information
  • Founded
  • MREO 2015
  • BBCP 1983
  • Country
  • MREO United Kingdom
  • BBCP United States
  • Employees
  • MREO N/A
  • BBCP N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • BBCP Engineering & Construction
  • Sector
  • MREO Health Care
  • BBCP Consumer Discretionary
  • Exchange
  • MREO Nasdaq
  • BBCP Nasdaq
  • Market Cap
  • MREO 369.2M
  • BBCP 302.4M
  • IPO Year
  • MREO N/A
  • BBCP 2017
  • Fundamental
  • Price
  • MREO $2.30
  • BBCP $6.18
  • Analyst Decision
  • MREO Strong Buy
  • BBCP Buy
  • Analyst Count
  • MREO 7
  • BBCP 4
  • Target Price
  • MREO $7.71
  • BBCP $7.83
  • AVG Volume (30 Days)
  • MREO 1.7M
  • BBCP 187.5K
  • Earning Date
  • MREO 05-14-2025
  • BBCP 06-05-2025
  • Dividend Yield
  • MREO N/A
  • BBCP N/A
  • EPS Growth
  • MREO N/A
  • BBCP N/A
  • EPS
  • MREO N/A
  • BBCP 0.28
  • Revenue
  • MREO N/A
  • BBCP $414,608,000.00
  • Revenue This Year
  • MREO N/A
  • BBCP N/A
  • Revenue Next Year
  • MREO $61.92
  • BBCP $6.18
  • P/E Ratio
  • MREO N/A
  • BBCP $21.74
  • Revenue Growth
  • MREO N/A
  • BBCP N/A
  • 52 Week Low
  • MREO $1.58
  • BBCP $4.78
  • 52 Week High
  • MREO $5.02
  • BBCP $9.68
  • Technical
  • Relative Strength Index (RSI)
  • MREO 52.99
  • BBCP 58.24
  • Support Level
  • MREO $1.58
  • BBCP $5.10
  • Resistance Level
  • MREO $2.37
  • BBCP $5.83
  • Average True Range (ATR)
  • MREO 0.21
  • BBCP 0.30
  • MACD
  • MREO 0.04
  • BBCP 0.14
  • Stochastic Oscillator
  • MREO 91.19
  • BBCP 93.10

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.

Share on Social Networks: